BIOBAT INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2010

Legal Domicile

Principal Officer

A JEFFREY ROSEN

Phone

3477991477

Tax Period

2024-07-01 to 2025-06-30

BIOBAT INC, founded in 2010, is a community nonprofit in the Community Improvement sector that reported $2.0M in total revenue in fiscal year 2024. Revenue fell 43% from the prior year — a significant decline worth monitoring. Expenses of $3.3M exceeded revenue, resulting in a 66% operating deficit.

Mission

BIOBAT, A JOINT PARTNERSHIP, CREATED BY THE RESEARCH FOUNDATION FOR SUNY, ON BEHALF OF DOWNSTATE HEALTH SCIENCES UNIVERSITY, AND THE NEW YORK CITY ECONOMIC DEVELOPMENT CORPORATION, PROVIDES:- SOPHISTICATED RESEARCH, OFFICE AND MANUFACTURING SPACE FOR LOCAL, NATIONAL AND INTERNATIONAL BIOTECHNOLOGY AND RELATED COMPANIES- THE OPPORTUNITY TO WORK WITH SUNY DOWNSTATE SCIENTISTS / CLINICIANS / STUDENTS TO ADVANCE THEIR DISCOVERIES AND PERFORM CLINICAL TRIALS- EDUCATIONAL, ENTREPRENEURIAL AND JOB TRAINING OPPORTUNITIES- AN ECONOMIC ENGINE TO CREATE JOBS, ADVANCE KNOWLEDGE AND BRING MEDICAL TREATMENTS AND NEW TECHNOLOGIES TO THE MARKETPLACE.

Program Service Accomplishments

Program 1

Expenses: $2,812,497 Revenue: $1,973,906

BIOBAT HOLDS A LEASE INTEREST IN A PORTION OF THE BROOKLYN ARMY TERMINAL AND IS COMMITTED TO CREATING A 21ST CENTURY WORKING WATERFRONT. THUS FAR GOVERNMENT FUNDING HAS ALLOWED BIOBAT TO ACQUIRE...

BIOBAT HOLDS A LEASE INTEREST IN A PORTION OF THE BROOKLYN ARMY TERMINAL AND IS COMMITTED TO CREATING A 21ST CENTURY WORKING WATERFRONT. THUS FAR GOVERNMENT FUNDING HAS ALLOWED BIOBAT TO ACQUIRE, MAINTAIN AND DEVELOP THIS LEASEHOLD INTEREST, AS WELL AS DEVELOP SPACE FOR INNOVATIVE COMPANIES TO APPLY FOR OCCUPANCY AND ENTER INTO LEASES FOR SPACE. BY PROVIDING THESE FACILITIES AND RELATED SUPPORT FOR THE APPLICATION, EXPANSION AND COMMERCIALIZATION OF BIOTECHNOLOGY, LIFE SCIENCES, AND HARD SCIENCES RESEARCH AT THE BROOKLYN ARMY TERMINAL, BIOBAT FULFILLS ITS MISSION. THE DEVELOPMENT OF THE SPACE AT BIOBAT IS BEING DONE IN PHASES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $1,973,906

Investment Income $0

Other Revenue $8,227

TOTAL REVENUE $1,982,133

Expense Breakdown

Grants Paid $0

Salaries & Benefits $316,107

Fundraising Expenses $0

Program Expenses $2,812,497

Other Expenses $2,974,204

TOTAL EXPENSES $3,290,311

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,982,133	$3,492,118	-0.4%
Expenses	$3,290,311	$4,273,424	-0.2%
Net Income	$-1,308,178	$-781,306	+0.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✓ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$240,419

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
CHRISTINE PAGLIALUNGA	CHAIR	1.00	Officer Director	$0	$0	$0
DR WAYNE RILEY MD	VICE CHAIR	1.00	Officer Director	$0	$0	$0
JOSHUA GONZALEZ	SECRETARY	1.00	Officer Director	$0	$0	$0
MATTTHEW MROZ	DIRECTOR	1.00	Director	$0	$0	$0
DAVID CHRISTINI PHD	DIRECTOR	1.00	Director	$0	$0	$0
HAZEL BALABAN	DIRECTOR	1.00	Director	$0	$0	$0
JAMES GIBALDI	DIRECTOR	1.00	Director	$0	$0	$0
JOAN BARTOLOMEO	DIRECTOR	1.00	Director	$0	$0	$0
CHRISTINA DEROSE	DIRECTOR	1.00	Director	$0	$0	$0
PREM PREMSRIRUT MD PHD	DIRECTOR	1.00	Director	$0	$0	$0
A JEFFREY ROSEN	TREASURER	1.00	Officer	$0	$0	$0
THOMAS HALL	EXECUTIVE DIRECTOR	40.00	Officer	$224,161	$16,258	$240,419

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$1,982,133	$3,290,311	$24,486,871	$-1,308,178
2024	$3,492,118	$4,273,424	$26,153,116	$-781,306
2023	$3,340,515	$4,007,602	$27,576,453	$-667,087
2022	$3,125,444	$2,602,971	$28,285,839	$522,473
2021	$3,841,164	$3,047,934	$27,575,878	$793,230
2020	$3,543,927	$2,827,638	$26,658,147	$716,289
2019	$2,307,303	$3,056,364	$47,760,979	$-749,061
2018	$2,292,271	$3,860,630	$48,957,848	$-1,568,359
2018	$2,292,271	$2,562,027	$49,650,170	$-269,756
2017	$1,816,098	$2,673,031	$49,866,062	$-856,933